rupatadine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aman, SAB; Dissanayake, H; Fernando, S; Ginneliya, A; Gomes, L; Idampitiya, D; Jeewandara, C; John, AS; Madushanka, P; Malavige, GN; Ogg, GS; Paranavitane, S; Prathapan, S; Punchihewa, C; Samarasekara, S; Wanigatunga, C; Wijewickrama, A | 1 |
| Bagriyanik, AH; Firinci, F; Karaman, M; Karaman, O; Kiray, M; Tuncel, T; Uysal, P; Uzuner, N; Yilmaz, O | 1 |
2 other study(ies) available for rupatadine and Disease Models, Animal
| Article | Year |
|---|---|
A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.
Topics: Acute Disease; Adult; Animals; Anti-Allergic Agents; Blood Platelets; Cyproheptadine; Dengue; Dengue Virus; Disease Models, Animal; Double-Blind Method; Endothelium; Female; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Preliminary Data; Sri Lanka; Treatment Outcome | 2018 |
The effect of rupatadine on lung histopathology in a murine model of chronic asthma.
Topics: Animals; Asthma; Cyproheptadine; Disease Models, Animal; Histamine H1 Antagonists, Non-Sedating; Histocytochemistry; Lung; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Ovalbumin; Random Allocation; Specific Pathogen-Free Organisms | 2013 |